Translational Research

Active nutrients: a synergistic attack to malignant mesothelioma
details

Agonist activation of estrogen receptor beta (ERbeta) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity
details

Anti-survivin vaccine for human use
details

Evaluation of GRP78 and the eIF6 transcription factor in malignant mesothelioma
details

Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells
details

Identification of the mechanisms of resistance and new molecular targets in stem cells derived from human malignant pleural mesothelioma
details

Mutations within tyrosine kinase receptors (TKR) as resistance markers to targeted therapy for pleural mesothelioma.
details

Preclinical evaluation of new treatments for malignant pleural mesothelioma (MPM)
details

Study of the tyrosine kinase receptor RON as a potential therapeutic target in mesothelioma
details

Tamoxifen as a Potential Therapeutic in Malignant Pleural Mesothelioma
details